ATRC AtriCure, Inc.
$61.42▼ -0.15%
Healthcare
Other
After hours
$61.69▲ +0.43%
Oct 28, 4:46 PM ET
Volume 647.5K
Avg Volume (10D) 651.3K
Key Metrics & Fundamentals
Market Cap
$3.12B
P/E Ratio
292.5
Div Yield
0.00%
52W Range
25.36 - 63.00
% vs 50 MA
11.65%
% vs 200 MA
62.33%
RSI-14
66.2
MACD Histogram
+0.3500
Beta (1Y vs SPY)
0.53
Free Cash Flow
$18.43M
Gross Rev
$153.60M
Gross Profit
$118.63M
EBITDA
$16.05M
COGS
$34.98M
Operating Exp
$108.96M
Operating Income
$9.67M
EBIT
$9.67M
Pretax Income
$9.43M
Net Income
$8.96M
EPS (Diluted)
0.18
Price & Volume History
Loading chart…
Recent News
AtriCure to Participate at Upcoming Investor Conferences
Business Wire · Oct 26, 2026 8:00 AM ET
AtriCure to Announce Third Quarter 2026 Financial Results
Business Wire · Oct 13, 2026 8:00 AM ET
AtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And Risks
Simply Wall St. · Oct 4, 2026 8:19 PM ET
AtriCure (ATRC) Stock Looks Rich Against Its Sales Base
Simply Wall St. · Sep 25, 2026 7:07 PM ET
Why AtriCure (ATRC) Is Back In The Spotlight
Simply Wall St. · Sep 25, 2026 1:14 PM ET
Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing
MT Newswires · Sep 24, 2026 5:10 PM ET
AXT Inc. (AXTI) Climbs 16% on S&P 600 Addition
Insider Monkey · Sep 21, 2026 4:00 PM ET
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Zacks · Sep 14, 2026 9:40 AM ET
AtriCure CTO Sells 3,657 Shares
Motley Fool · Sep 12, 2026 8:05 PM ET
Do Options Traders Know Something About AtriCure Stock We Don't?
Zacks · Sep 10, 2026 10:39 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ATRC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.